Breaking Nephrology | Physician's Weekly
Advertisement

Breaking Nephrology

Dapagliflozin Gets FDA Nod For Treatment of CKD

New indication expands the use of the oral diabetes drug Dapagliflozin (Farxiga) won FDA approval for use for patients with chronic kidney disease who are at risk of disease progression. The oral tablets showed efficacy in a...

Loading

Advertisement

For latest news and updates
Email-id is invalid